NVS Novartis AG

90.530.13 (+0.14%)
Close: November 20, 2019

Quote

Previous Close
$90.53
Day Range
$90.23-$90.69
52 Week Range
$74.97-$96.31
Volume
1,310,225
Avg Volume
1,671,956
Dividend TTM
$1.84 (2.04%)
Ex-Dividend Date
2019-03-04

Valuation

Market Cap
$207.13B
Enterprise Value (EV)
$222.97B
PE Ratio
17.66
EV/EBITDA
14.73
Price/Sales
3.98
Price/Book
2.63
PEG Ratio
0.85

Financials

Revenue
$52.02B
Gross Profit
$33.57B
EBITDA
$15.14B
EPS, ttm
$5.13
Profit Margin
24.30%
Revenue/Employee
$415.61K
Next Earnings Date
1/29/2020 (70 days)
Debt to Equity
41%
Debt
$31.79B
Cash
$15.95B
Net Debt
$15.84B

Performance

Beta
0.46
200 Day Moving Avg
$88.29
50 Day Moving Avg
$87.22
52 Week Change
3.97%
YTD Change
7.69%
1 Month Change
4.44%
3 Month Change
1.48%
6 Month Change
10.23%
1 Year Change
3.97%
2 Year Change
8.63%
5 Year Change
-5.57%

Share Count

Shares Outstanding
2.3B
Float
2.3B
Restricted Shares
22.9K
Restricted Shares, %
0.00%

Novartis AG Company Details

Sector: Health Technology

Industry: Pharmaceuticals: Major

CEO: Vasant Narasimhan

Website: http://www.novartis.com

Description: Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Employees: 125,161